Engineers Gate Manager LP Chimerix Inc Transaction History

Engineers Gate Manager LP

  • $4.27 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.9 - $1.06 $179 - $210
-199 Reduced 0.82%
24,102 $23,000
Q3 2023

Nov 14, 2023
BUY
$0.94 - $1.23 $1,592 - $2,083
1,694 Added 7.49%
24,301 $23,000
Q2 2023

Aug 14, 2023
BUY
$1.1 - $1.54 $24,867 - $34,814
22,607 New
22,607 $27,000
Q2 2022

Aug 15, 2022
SELL
$1.34 - $5.34 $15,657 - $62,397
-11,685 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$4.58 - $6.8 $53,517 - $79,458
11,685 New
11,685 $54,000

Others Institutions Holding CMRX

# of Institutions
81
Shares Held
36.8M
Call Options Held
72.2K
Put Options Held
169K
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email